GoodRx Leaked User Health Data To Facebook and Google, FTC Says

An anonymous reader quotes a report from The New York Times: Millions of Americans have used GoodRx, a drug discount app, to search for lower prices on prescriptions like antidepressants, H.I.V. medications and treatments for sexually transmitted diseases at their local drugstores. But U.S. regulators say the app's coupons and convenience came at a high cost for users: wrongful disclosure of their intimate health information. On Wednesday, the Federal Trade Commission accused the app's developer, GoodRx Holdings, of sharing sensitive personal data on millions of users' prescription medications and illnesses with companies like Facebook and Google without authorization.

From 2017 to 2020, GoodRx uploaded the contact information of users who had bought certain medications, like birth control or erectile dysfunction pills, to Facebook so that the drug discount app could identify its users' social media profiles, the F.T.C. said in a legal complaint. GoodRx then used the personal information to target users with ads for medications on Facebook and Instagram, the complaint said, 'all of which was visible to Facebook.' GoodRx also targeted users who had looked up information on sexually transmitted diseases on HeyDoctor, the company's telemedicine service, with ads for HeyDoctor's S.T.D. testing services, the complaint said. Those data disclosures, regulators said, flouted public promises the company had made to 'never provide advertisers any information that reveals a personal health condition.'

The company's information-sharing practices, the agency said, violated a federal rule requiring health apps and fitness trackers that collect personal health details to notify consumers of data breaches. While GoodRx agreed to settle the case, it said it disagreed with the agency's allegations and admitted no wrongdoing. The F.T.C.'s case against GoodRx could upend widespread user-profiling and ad-targeting practices in the multibillion-dollar digital health industry, and it puts companies on notice that regulators intend to curb the nearly unfettered trade in consumers' health details. If a judge approves the proposed federal settlement order, GoodRx will be permanently barred from sharing users' health information for advertising purposes. To settle the case, the company also agreed to pay a $1.5 million civil penalty for violating the health breach notification rule.

Read more of this story at Slashdot.